Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a duly signed Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022. Supriya Lifescience Ltd - 543434 - Attestation Of Inspection (EU-GMP) Granted By European Directorate For The Quality Of Medicines (EDQM)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that, The European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra. This is for your information and records. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on January 2, 2023 via video conference. Supriya Lifescience Ltd - 543434 - Closure of Trading Window
In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct to Regulate, Monitor and Report Trading in Securities by Insiders (hereinafter referred to as the "Prohibition of Insider Trading Code"), the Trading window for dealing in the Securities of the Company for all the Insiders, Designated Persons (including their immediate relatives), as defined in the Code, shall remain closed from January 01, 2023 till the expiry of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. Supriya Lifescience Ltd - 543434 - Intimation Regarding Captive Solar Project Agreement Signed With Enrich Energy Pvt. Ltd
We wish to inform you that Supriya Lifescience Ltd. has signed an agreement with Pune based Enrich Energy Pvt Ltd. to develop 4.68 MWp DC Solar Photovoltaic Power project at Site Nanded, Maharashtra. This project will generate & supply Green Energy to fulfill about 50% present consumption of the company & reduce Carbon Emission equivalent to 6830 Tons per annum. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on December 14, 2022 & December 15, 2022, via video conference and in person meeting respectively. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will participate in conference and interact with Investors /Analysts in person on December 7, 2022. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on December 1, 2022 via in person meeting. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on November 30, 2022 via in person meeting. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on 25th November 2022 via in person meeting.